Acetic Acid → Tedatioxetine Hydrobromide

HRID 2069165Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 2069165
[C:1]1([CH3:25])[CH:6]=[CH:5][C:4]([S:7][C:8]2[CH:13]=[CH:12][CH:11]=[CH:10][C:9]=2[CH:14]2[CH2:19][CH2:18][N:17](C(OCC)=O)[CH2:16][CH2:15]2)=[CH:3][CH:2]=1.[BrH:26].C(O)(=O)C>>[BrH:26].[C:1]1([CH3:25])[CH:2]=[CH:3][C:4]([S:7][C:8]2[CH:13]=[CH:12][CH:11]=[CH:10][C:9]=2[CH:14]2[CH2:15][CH2:16][NH:17][CH2:18][CH2:19]2)=[CH:5][CH:6]=1

Komponenten

4

Edukt 3

HCID 176Acetic AcidHCID 260Hydrogen BromideHCID 45258309Ethyl 4-(2-(4-tolylsulfanyl)phenyl)-piperidin-1-carboxylate

Produkt 1

HCID 24751582Tedatioxetine Hydrobromide

Reaktionsbedingungen

Temperatur
80 °C

Versuchsvorschrift

The crude ethyl 4-(2-(4-tolylsulfanyl)phenyl)-piperidin-1-carboxylate as a red oil from example 3 was mixed in a stirred reactor with hydrobromic acid in acetic acid (40%, 545 mL, 3.11 mol). The mixture was heated at 80° C. for 18 hours. The reaction mixture was cooled down to room temperature. During the cooling the product crystallises out. After 1 hour at room temperature ethyl ether (800 mL) was added to the reaction mixture, and the mixture was stirred for another hour. The product was filtered off, washed with ethyl ether and dried in a vacuum oven at 50° C. until constant weight.

Aufarbeitung

  1. temperatureThe reaction mixture was cooled down to room temperature
  2. customDuring the cooling the product crystallises out
  3. additionAfter 1 hour at room temperature ethyl ether (800 mL) was added to the reaction mixture
  4. filtrationThe product was filtered off
  5. washwashed with ethyl ether
  6. customdried in a vacuum oven at 50° C. until constant weight

Quellen und Nachweise

ORD-Eintrag
ord-12a4843750b3468ab1163a76875b56b4
Quelldatensatz
uspto-grants-2012_10
Patentnummer
US08299095B2

Notizen zur Reaktion

Wird geladen…